drugset / Trial / NCT07370220

Effect of Rutin on Inflammation Pathways in Ulcerative Colitis Patients

NCT07370220

Phase 2 Completed 60 enrolled Benha University
Non-randomizedParallel-groupSingle-blindSupportive care

Summary

This study evaluates the therapeutic role of Rutin (a plant-derived flavonoid) in reducing the severity of Ulcerative Colitis (UC). The study investigates whether Rutin can decrease intestinal inflammation and improve clinical symptoms by inhibiting the NLRP3 inflammasome signaling pathway, which is activated by oxidative stress in the colon.

Timeline

Start
2025-02-22
Primary completion
2025-05-25
Completion
2025-11-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rutin Unknown 500 mg Oral

Indications